Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders
帕博利珠单抗治疗晚期肛门鳞状细胞癌疗效的生物标志物:一项 II 期临床试验和长期缓解者队列研究的分析
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2023-008436
Huffman, Brandon M; Singh, Harshabad; Ali, Lestat R; Horick, Nora; Wang, S Jennifer; Hoffman, Megan T; Metayer, Katherine A; Murray, Shayla; Bird, Alexandra; Abrams, Thomas A; Biller, Leah H; Chan, Jennifer A; Meyerhardt, Jeffrey A; McCleary, Nadine J; Goessling, Wolfram; Patel, Anuj K; Wisch, Jeffrey S; Yurgelun, Matthew B; Mouw, Kent; Reardon, Brendan; Van Allen, Eliezer M; Zerillo, Jessica A; Clark, Jeffrey W; Parikh, Aparna; Mayer, Robert J; Schlechter, Benjamin; Ng, Kimmie; Kumar, Sunil; Del Vecchio Fitz, Catherine; Kuperwasser, Charlotte; Hanna, Glenn J; Coveler, Andrew L; Rubinson, Douglas A; Welsh, Emma L; Pfaff, Kathleen; Rodig, Scott; Dougan, Stephanie K; Cleary, James M